Aneurysm Clips Market By Material Type (Titanium, Cobalt-Chromium, Others); By Aneurysm Type (Saccular, Fusiform & Dissecting); By End User (Hospitals & Neurosurgical Centers, Ambulatory Surgical Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aneurysm Clips Market is projected to reach USD 89.6 million by 2030 , up from an estimated USD 62.8 million in 2024 , reflecting a compound annual growth rate (CAGR) of 6.1% between 2024 and 2030. According to Strategic Market Research, this market is moving through a period of structural change — driven by technology refinement, procedural shifts in neurosurgery, and the continuing global burden of cerebrovascular diseases.

 

Aneurysm clips are small, mechanical implants designed to occlude cerebral aneurysms and prevent subarachnoid hemorrhage. Although it’s a narrow segment within neurosurgical implants, it’s strategically vital. Unlike stents or coils, which are deployed endovascularly , aneurysm clips are used in open surgical interventions , where permanence, mechanical reliability, and biocompatibility are non-negotiable.

 

From a clinical standpoint, the burden is growing. The World Stroke Organization estimates that over 3% of adults globally may have unruptured intracranial aneurysms — many requiring lifelong monitoring or intervention. As diagnostic imaging improves and incidental aneurysm detection rises, the demand for clipping procedures — though more selective than coiling — remains steady among complex and wide-neck aneurysm cases.

 

Over the past decade, treatment patterns have shifted. Endovascular coiling dominates early or smaller lesions, but microsurgical clipping still stands as the gold standard for complex, broad-necked, and ruptured aneurysms . Neurosurgeons now prefer titanium or cobalt-chromium clips for their MRI compatibility, elasticity, and fatigue resistance. These material improvements have directly influenced long-term outcomes, reducing slippage risk and improving vessel preservation.

 

Technological progress has been subtle but important. Clip design optimization through finite element modeling, automated closing force calibration, and 3D-printed training models have elevated procedural safety. Modern systems now allow intraoperative visualization and force measurement, ensuring uniform occlusion without arterial damage. That shift — from manual craftsmanship to data-guided precision — marks a quiet revolution in how aneurysm clipping is practiced today.

 

Beyond hospitals, the stakeholder map is diverse. OEMs like Aesculap (B. Braun) , Mizuho Medical , and Integra LifeSciences dominate the supply chain, while university hospitals and neurosurgical research centers push innovation boundaries through trials in hybrid operating rooms. Regulatory agencies, particularly the FDA and EMA , continue to tighten standards for implant traceability and material testing, leading to slower but safer product cycles.

 

In emerging markets, the narrative is slightly different. China, India, and Brazil are witnessing increased neurosurgical infrastructure investment. New specialized centers are being equipped with advanced microscopes, neuronavigation systems, and compatible clip applicators. However, in resource-limited regions, lack of training and cost sensitivity remain barriers. This has prompted some manufacturers to introduce cost-adjusted clip systems — maintaining ISO standards but with simplified delivery tools.

 

At its core, this market doesn’t grow on hype but on clinical trust . Every clip implanted represents a lifetime decision. That’s why surgeons lean toward proven brands and designs, even at higher costs. The innovation challenge for the next decade will revolve around materials science — finding the balance between elasticity, biostability , and imaging compatibility without compromising cost or surgical familiarity.

 

To be candid, aneurysm clipping may never be a high-volume segment, but it’s a high-stakes one . And as neurosurgery becomes more image-guided and robotic-assisted, the demand for precision-engineered, traceable, and MRI-safe clips will keep this market both relevant and resilient through 2030.

 

Market Segmentation And Forecast Scope

The aneurysm clips market is defined by the delicate intersection of precision engineering, surgical technique, and material science. Segmentation reflects how hospitals and neurosurgeons balance procedural reliability with imaging safety and cost-efficiency. Based on current clinical and commercial dynamics, the market can be segmented by Material Type , Aneurysm Type , End User , and Region .

By Material Type

Titanium Clips
Titanium remains the benchmark material, accounting for roughly 57% of total market share in 2024 . Its key appeal lies in being non-ferromagnetic , ensuring MRI compatibility up to 3 Tesla. Titanium clips are lighter, corrosion-resistant, and exhibit strong fatigue endurance — essential for long-term occlusion. They’ve become the default choice for complex intracranial aneurysm surgeries, particularly in MRI-dependent hospitals.

Cobalt-Chromium ( Phynox ) Clips
These clips are gaining traction as they offer higher closing force per unit size — ideal for narrow surgical spaces and broad-neck aneurysms. While still metal-based, they’re increasingly used in hybrid operating suites where surgeons want a combination of strength and flexibility. This segment is expected to grow fastest, at around 7.2% CAGR , as more neurosurgeons transition toward advanced alloy-based clips for challenging anatomies.

Other Materials (Tantalum, Stainless Steel)
Once widely used, these are now niche — mostly in developing regions or for teaching purposes. The MRI limitations and higher corrosion risk have reduced adoption significantly.

 

By Aneurysm Type

Saccular (Berry) Aneurysms
These account for the majority of procedures and represent nearly 70% of all clip placements . The clip geometry in this category emphasizes precise neck occlusion without impinging nearby vessels. Manufacturers have standardized blade angulations and spring forces specifically for saccular variants.

Fusiform and Dissecting Aneurysms
Although less common, these demand highly customized clip shapes, often in tandem with bypass procedures. The trend toward patient-specific clip sets — pre-selected using 3D angiographic modeling — is expected to redefine this category by 2030.

 

By End User

Hospitals & Neurosurgical Centers
They dominate the landscape, representing about 82% of total demand . Large tertiary and academic centers handle most complex cases and serve as key customers for OEMs like Aesculap , Mizuho , and Codman & Shurtleff . Their purchasing decisions emphasize reliability, sterilization standards, and post-market traceability.

Ambulatory Surgical Centers (ASCs)
Still a small but emerging segment, particularly in developed markets such as the U.S. and Japan. ASCs conduct select aneurysm repairs in stable, pre-diagnosed cases — typically unruptured , elective interventions.

Academic & Research Institutes
A minor segment but strategically vital. These institutions test new clip mechanisms, force calibration tools, and robotic-assisted delivery systems — often in collaboration with OEMs or funded by neurosurgical societies.

 

By Region

North America
Leads the global market with well-established neurosurgical programs, stringent device regulations, and widespread MRI-compatible system adoption. The U.S. alone accounts for nearly one-third of total global revenues.

Europe
A close second, driven by precision device manufacturing in Germany, Switzerland, and France . The European regulatory framework strongly favors titanium-based clips due to harmonized safety and biocompatibility directives.

Asia Pacific
Expected to post the highest CAGR (~8%), led by expanding surgical volumes in China, Japan, and India . Local production by regional players is also improving cost competitiveness .

Latin America and Middle East & Africa (LAMEA )
These regions remain underpenetrated but are catching up through medical tourism and new neurosurgical training initiatives. Growth is slower but steady as tertiary centers adopt Western surgical standards.

Scope Note : While this segmentation appears primarily technical, it reflects deeper industry trends. The shift from manual clip customization to pre-validated clip systems mirrors a broader transformation in neurosurgery — from craft-based practice to data-driven standardization. By 2030, most aneurysm clips are expected to be sold as part of integrated neurosurgical kits , complete with applicators, sterilization trays, and digital traceability features.

 

Market Trends And Innovation Landscape

The aneurysm clips market is in a quiet but meaningful transformation. Innovation isn’t loud here — it’s measured in millimeters, metallurgy, and motion control. The next generation of aneurysm clips is less about introducing radical new designs and more about enhancing consistency, compatibility, and intraoperative intelligence.

Precision Manufacturing and Design Evolution

Clip design has reached a point of high refinement, but micro-adjustments continue to matter. Modern clips now incorporate computer-aided tolerance calibration to ensure consistent closing force across batches — a major quality control leap. Vendors are introducing torque-balanced springs that prevent asymmetric closing, reducing vessel trauma. Advanced CNC machining and 3D laser polishing have nearly eliminated burr formation, improving tissue safety and longevity. Some premium models now come with color-coded force indicators on the applicators, allowing surgeons to verify closing pressure in real time.

What’s driving this? The demand for predictability in the operating room . When neurosurgeons are working millimeters from vital brain structures, precision isn’t optional — it’s existential.

 

Material Science and MRI Safety

The industry’s biggest material shift is already underway. The move from stainless steel and tantalum to titanium and cobalt-chromium alloys has made modern clips fully MRI-compatible, even under high-field 7T research scanners. These alloys provide superior biocompatibility and long-term structural stability without corroding or interfering with post-op imaging.

There’s also growing interest in polymer-coated clip systems , which reduce metal artifacting and may allow for enhanced intraoperative fluorescence imaging . Some R&D labs are testing hybrid composite materials that combine metallic strength with polymeric imaging transparency — a direction that could redefine surgical visualization standards by 2030.

 

Digital Integration and Robotic Assistance

Although clipping remains a manual art, the rise of robot-assisted neurosurgery is slowly reshaping procedural workflows. Companies are experimenting with digitally guided applicators that integrate neuronavigation data, ensuring precise clip placement along 3D vessel trajectories. These systems, while still in prototype, could soon assist surgeons in planning clip orientation and predicting closure impact before making a single incision.

Intraoperative visualization tools — especially indocyanine green (ICG) fluorescence and intraoperative 3D angiography — are now standard in advanced centers. Vendors are aligning clip design with these modalities, using matte finishes and anti -glare coatings to improve visibility under surgical microscopes.

 

3D Printing and Patient-Specific Training Models

Simulation-based training is gaining ground. Neurosurgical academies are using 3D-printed brain and vessel models derived from patient CT angiography scans to rehearse clipping procedures. OEMs now collaborate with universities to produce clip simulation kits that mirror real tactile feedback. This trend isn’t just about skill-building; it’s a subtle marketing evolution — the clip brands used in training often become the surgeon’s preference in real cases.

 

Sterility and Traceability Upgrades

Post-market surveillance rules, especially under EU MDR (Medical Device Regulation) , have reshaped product tracking. Each clip now carries a unique device identifier (UDI) that integrates into electronic surgical records. Hospitals can trace every implant back to production lots, an advancement that enhances both accountability and clinical governance.

Several companies are also shifting to pre-loaded sterile clip cartridges , reducing surgical setup time and minimizing contamination risks. This change, though operational, reflects a broader convergence between neurosurgery and lean manufacturing principles.

 

Expert Insight

Neurosurgeons today don’t just want a clip — they want a system. That system includes predictive planning software, ergonomic applicators, and validated force metrics. It’s a subtle convergence of mechanical engineering, materials science, and digital integration that’s making aneurysm surgery more reproducible, safer, and data-driven.

As one European neurosurgeon put it, “We’ve stopped thinking about clips as tools — they’re now precision instruments built for the digital OR.”

 

Competitive Intelligence And Benchmarking

The aneurysm clips market is small but fiercely specialized — dominated by a handful of companies that have spent decades refining the precision, reliability, and surgical ergonomics of their clip systems. Each player has carved a niche strategy around manufacturing quality, clinical trust, and global service networks. Unlike broader medical device segments, competition here is not about volume — it’s about credibility at the operating table .

Aesculap (a B. Braun company)

Aesculap remains the undisputed leader, commanding an estimated 40–45% global market share . Its Yasargil clip system , named after the pioneer of microsurgical aneurysm repair, has become the de facto standard in many neurosurgical centers. The company’s edge lies in unmatched mechanical precision — with every clip undergoing 100% closing force verification before packaging. Aesculap also provides full-system integration — from titanium clips to sterilization trays and applicators. Their long-term partnership model with hospitals — offering training, device maintenance, and clinical workshops — reinforces brand loyalty. Recent investments in titanium- phynox hybrids underline their focus on biomechanical innovation.

 

Mizuho Medical Co., Ltd.

Based in Japan, Mizuho is known for its deep engineering pedigree. The company manufactures Sugita clips , widely recognized for their broad design range and consistent spring force. Mizuho emphasizes modularity — offering more than 60 clip configurations to fit different aneurysm morphologies. The company’s R&D efforts are concentrated on MRI-safe cobalt-chromium designs and anti-glare coatings for fluorescence-guided surgery. Mizuho’s strategic partnerships with Japanese and European hospitals for product co-development make it one of the most trusted brands in academic neurosurgery.

 

Integra LifeSciences

Integra has been strategically positioning itself in the neurocritical care segment, with aneurysm clips complementing its cranial access and dural repair portfolios. Its focus isn’t on clip variety but on integrating clips into procedural ecosystems — offering bundled systems with micro-instruments and surgical navigation tools. In North America, Integra’s presence is strong in teaching hospitals, where procedural standardization matters as much as device performance. The company’s ongoing push toward robotic-compatible applicators signals its intent to play long-term in digital neurosurgery.

 

Codman & Shurtleff (Johnson & Johnson)

Although now a quieter player following internal portfolio restructuring, Codman still retains strong clinical trust in legacy markets. Their aneurysm clips are known for durable spring mechanisms and compatibility with older surgical systems, making them a preferred choice in several U.S. institutions. That said, Codman’s innovation pace has slowed compared to newer entrants. Its strength lies in brand heritage and long-standing distribution networks across North America and Europe.

 

Peter Lazic GmbH

A rising name from Germany, Peter Lazic has built a reputation around precision-engineered titanium clips designed with ergonomic applicator systems. The company differentiates through surgeon-centered design workshops , co-developing clip angles and blade lengths with real neurosurgeons. Their product design philosophy emphasizes “ease in complexity” — fewer clip variants but higher adaptability. This consultative model has helped the brand secure adoption in leading European teaching hospitals.

 

ADEPT Medical and Emerging Entrants

Smaller OEMs like ADEPT Medical , KLS Martin , and a few Chinese manufacturers are trying to enter the lower-cost segment, primarily serving public hospitals and regional neurosurgical programs. They focus on titanium imitation systems and cost-optimized sterilization kits. However, brand acceptance remains limited due to the dominance of long-established manufacturers.

 

Regional Landscape And Adoption Outlook

The aneurysm clips market exhibits sharp regional contrasts, not just in procedure volumes but in surgical philosophy, regulatory maturity, and material adoption. Developed regions dominate revenue, while emerging markets hold the growth potential — driven by rising stroke awareness and neurosurgical capacity-building. Let’s unpack the regional patterns shaping this market’s evolution through 2030.

North America

North America remains the epicenter of aneurysm clip utilization, supported by robust neurosurgical infrastructure, MRI-based postoperative follow-up , and early adoption of titanium and cobalt-chromium clips . The United States accounts for over 35% of global revenue , with leading academic centers such as Mayo Clinic , Johns Hopkins , and Cleveland Clinic performing thousands of aneurysm repair procedures annually.

Regulatory stringency under the FDA’s Class III medical device pathway ensures high mechanical and biocompatibility standards, keeping the market concentrated among trusted OEMs like Aesculap , Codman , and Integra LifeSciences . Hospitals increasingly favor clip systems pre-integrated with microsurgical tools and neuronavigation compatibility , aligning with the growing use of intraoperative imaging.

In Canada , adoption is slower but trending upward, especially within tertiary hospitals investing in hybrid neurosurgical suites. The rise in elective aneurysm clipping procedures for unruptured cases also supports stable demand.

Regional insight: North America’s focus isn’t on growing volume, but on zero-error surgery — the clip market’s long-term strength here comes from reliability, not replacement.

 

Europe

Europe’s aneurysm clip landscape is anchored by engineering excellence and a deep bench of specialized neurosurgeons . Germany, Switzerland, and France dominate both production and usage. Aesculap and Peter Lazic GmbH are headquartered here, enabling short supply chains and precision manufacturing control.

Regulatory convergence under the EU MDR (Medical Device Regulation) has reshaped procurement patterns, requiring robust clinical evaluation and traceability. Hospitals are moving toward MRI-conditional titanium clips to align with stricter post-surgical imaging protocols. The UK and Nordic countries are emphasizing health economics — pushing for reusable applicators and standardized tray systems to cut costs.

Central and Eastern Europe are still catching up. In countries like Poland, Hungary, and the Czech Republic, public hospitals rely heavily on state tenders, often sourcing from cost-efficient OEMs or regional distributors. Training programs, supported by European neurosurgical societies, are improving surgical proficiency — an indirect catalyst for higher adoption over time.

 

Asia Pacific

This is the fastest-growing regional market , expanding at an estimated CAGR of 8.3% through 2030. Key growth engines include China, Japan, India, and South Korea , each at a different maturity level.

Japan is a long-standing hub due to domestic manufacturing by Mizuho Medical , whose Sugita clips are widely used in both domestic and export markets. Japan’s neurosurgical institutions set global benchmarks in microsurgical training and hybrid OR usage.

China and India are scaling rapidly, driven by increasing intracranial aneurysm diagnosis rates, improving access to MRI, and expanding tertiary hospital networks. However, procedural volumes are still constrained by the availability of trained neurosurgeons. Local manufacturers are entering the market with cost-adjusted titanium clips , though adoption remains limited in premium hospitals, which continue to favor imported brands.

South Korea and Singapore represent advanced submarkets emphasizing robotic-assisted neurosurgery, where high-precision clip systems with digital integration are preferred.

Insight: Asia Pacific’s real story isn’t just volume — it’s the migration of surgical skill and technology from high-income to middle-income economies. As more neurosurgeons train abroad and return home, the shift toward advanced clip systems accelerates.

 

Latin America

Latin America’s aneurysm clip market is modest but improving. Brazil and Mexico lead the region, supported by rising investments in neurovascular care and government-backed stroke centers. Private hospitals in São Paulo and Mexico City are now performing regular aneurysm clippings, adopting titanium systems from Aesculap and Mizuho . However, public hospitals still face procurement challenges and limited MRI access, which slows the adoption of advanced clip types.

Regional distribution remains fragmented, with OEMs depending on distributors and training workshops to expand surgeon familiarity.

 

Middle East & Africa (MEA)

MEA remains the smallest but emerging segment. Saudi Arabia and the UAE are investing in world-class neurosurgical centers under national health modernization plans. Partnerships with Western OEMs have helped equip hospitals with full neurovascular surgical systems, including aneurysm clips. In Africa , access is limited, though teaching hospitals in South Africa , Egypt , and Kenya are beginning to introduce microsurgical aneurysm programs with NGO support.

Growth in this region will depend on infrastructure readiness and surgeon training , not immediate product availability.

 

End-User Dynamics And Use Case

The aneurysm clips market revolves around a compact but high-value group of end users — mostly neurosurgical institutions with strong infrastructure, multidisciplinary teams, and strict procedural governance. Unlike consumable-heavy segments, aneurysm clip adoption is dictated by surgical specialization , clinical confidence , and capital access , not just device cost.

Hospitals and Neurosurgical Centers

These remain the undisputed backbone of the aneurysm clip market, accounting for nearly 83% of total usage in 2024. Large tertiary care hospitals and academic medical centers are the dominant purchasers, primarily because they handle the full spectrum of intracranial aneurysm cases — from emergency ruptures to elective microsurgeries.

High-volume institutions often have dedicated neurosurgical departments equipped with neuronavigation systems, intraoperative angiography, and hybrid operating rooms. In these environments, surgeons favor titanium or cobalt-chromium clips due to their MRI compatibility and reliable closure strength . OEMs like Aesculap and Mizuho Medical are preferred due to their proven mechanical repeatability and robust clinical validation.

Procurement decisions here are typically surgeon-driven rather than purely administrative. Once a surgical team becomes accustomed to a particular clip system, switching rarely occurs — creating decades-long brand loyalty. This procedural conservatism has kept new entrants from making quick inroads, even with lower prices.

 

Ambulatory Surgical Centers (ASCs)

While not major contributors yet, ASCs represent a slowly emerging niche, particularly in North America and Japan . These centers typically handle unruptured , elective aneurysm clippings that don’t require long post-operative ICU stays. The advantages lie in reduced hospital overhead , faster scheduling, and increasingly compact neurosurgical setups.

To cater to this shift, manufacturers are offering miniaturized clip applicator sets and pre-sterilized procedural kits that streamline workflow in smaller ORs. However, the complexity and risk of aneurysm clipping still limit widespread adoption in standalone ASCs. Only those with direct neurosurgical affiliations are expected to see moderate growth by 2030.

 

Academic & Research Institutes

This group plays a small but strategically crucial role. Universities and research hospitals act as training grounds for neurosurgeons and as testbeds for innovation . Manufacturers often collaborate with these centers to validate new clip geometries, test fatigue behavior under micro-force conditions, or simulate aneurysm repairs using 3D-printed vascular models.

These institutions are also leading in robot-assisted microsurgery and AI-driven intraoperative guidance research , areas where clip placement precision is being modeled digitally before actual surgery. The academic segment may not bring high commercial volume, but it strongly influences surgeon preferences — which in turn shape long-term brand loyalty.

 

Private Clinics and Specialty Units

This is an emerging sub-segment, particularly in Japan, South Korea, and parts of Europe , where experienced neurosurgeons run specialty practices within large hospital networks. These setups conduct selective aneurysm clipping procedures under contractual hospital affiliations. Their purchasing decisions often mirror their training institutions, further reinforcing the dominance of long-standing brands.

 

Representative Use Case: Hybrid Neurosurgical Suite in South Korea

A leading neurosurgical department in Seoul , operating within a university hospital, recently transitioned from mixed-material clips to next-generation titanium- phynox systems for all aneurysm cases. The decision followed a one-year pilot assessing MRI artifact interference, spring fatigue, and intraoperative performance.

The hospital also implemented ICG-guided fluorescence imaging to verify clip placement and vessel patency in real time. Over 150 procedures later, outcomes were striking — a 20% reduction in intraoperative repositioning events and a 15% decrease in postoperative imaging artifacts.

More importantly, the data was shared with the OEM, who used it to refine their clip design tolerances and applicator ergonomics. This closed feedback loop between hospital and manufacturer illustrates the evolving, partnership-driven nature of innovation in this field.

 

Recent Developments + Opportunities & Restraints

The aneurysm clips market may appear steady on the surface, but underneath lies steady movement — design refinements, collaborations between OEMs and neurosurgical centers, and technology spillovers from robotic and imaging platforms. Between 2023 and 2025, several small yet strategic developments have begun redefining the surgical precision and reliability expected in aneurysm clipping.

Recent Developments (2023–2025)

• Aesculap (B. Braun) announced in late 2024 the development of a hybrid titanium- phynox clip system tested for mechanical fatigue under extended thermal cycling — a feature designed to improve long-term vessel occlusion in high-stress regions. The company also introduced a QR-based device traceability system , integrating directly into hospital EMRs for regulatory compliance under EU MDR

• Mizuho Medical Co., Ltd. launched its Sugita 2.0 clip line in Japan in early 2024, optimized for robot-assisted clip placement . The design incorporates a modified hinge geometry and a high-visibility matte coating compatible with ICG fluorescence-guided imaging systems. The upgrade is seen as a step toward full integration with hybrid neurosurgical operating suites.

• Integra LifeSciences entered into a partnership with a European robotics startup to co-develop digital clip applicator systems . These applicators will enable real-time force feedback during surgery, allowing surgeons to visualize closing pressure before applying the clip — an innovation with the potential to reduce intraoperative vessel injury.

• Peter Lazic GmbH in Germany expanded its manufacturing capacity in 2023 to accommodate a new line of precision micro-clips for pediatric and small-vessel aneurysms, aiming to meet a growing need in pediatric neurosurgery and cerebrovascular malformation management.

• Codman & Shurtleff (under Johnson & Johnson) has been reorganizing its neurosurgery division, reportedly preparing a re-entry into the aneurysm clip segment with MRI-conditional clip systems tailored for North American hospitals that are replacing legacy stainless-steel units.
   

Opportunities

• Integration with Digital Neurosurgery Platforms
  The move toward hybrid operating rooms is accelerating demand for digitally assisted clip delivery systems . OEMs that can integrate clips with neuronavigation software or robotic guidance tools will capture new growth. Digital integration could transform mechanical tools into smart, data-capturing surgical instruments.

• Growth in Emerging Neurosurgical Centers
  Asia Pacific, Latin America, and the Middle East are expanding tertiary neurosurgical programs. As hospitals in China, India, and Brazil modernize with intraoperative MRI and 3D angiography, the need for MRI-safe clip systems is increasing. Local partnerships and affordable titanium variants present strong entry opportunities for mid-tier manufacturers.

• Material Innovation and Lightweight Design
  Titanium- phynox and next-generation cobalt-chromium alloys are enabling smaller, stronger clips that provide higher closing forces without structural fatigue. This opens the door for pediatric and micro-aneurysm applications — a niche yet expanding field.

• Training and Simulation Ecosystem
  The rising use of 3D-printed aneurysm models and AR-based microsurgical training systems is creating indirect demand for educational clip sets. OEMs supplying training-grade clips and simulation-compatible applicators could strengthen brand adoption early in surgeons’ careers.
   

Restraints

• High Cost of Premium Clip Systems
  Advanced titanium and hybrid alloy clips can be up to 40% more expensive than stainless-steel systems. This limits penetration in public hospitals and cost-sensitive regions, where procurement still favors conventional materials.

• Limited Skilled Workforce
  Microsurgical clipping is an elite procedure requiring years of experience. Many countries face a shortage of certified neurosurgeons trained in open aneurysm repair, constraining potential procedure volumes despite growing aneurysm detection rates.

• Competing Endovascular Alternatives
  Endovascular coiling and flow-diverter stents remain less invasive alternatives. While not suitable for all aneurysm types, their rising adoption in smaller aneurysms is reducing the overall clipping frequency in developed markets.
   

7.1. Report Coverage Table

Report Attribute	Details
Forecast Period	2024 – 2030
Market Size Value in 2024	USD 62.8 Million
Revenue Forecast in 2030	USD 89.6 Million
Overall Growth Rate	CAGR of 6.1% (2024 – 2030)
Base Year for Estimation	2024
Historical Data	2019 – 2023
Unit	USD Million, CAGR (2024 – 2030)
Segmentation	By Material, By Aneurysm Type, By End User, By Geography
By Material	Titanium, Cobalt-Chromium, Others
By Aneurysm Type	Saccular, Fusiform & Dissecting
By End User	Hospitals, ASCs, Academic Institutes
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Germany, Japan, China, India, Brazil, Saudi Arabia, etc.
Market Drivers	Advancements in MRI-compatible materials; Expanding neurosurgical capacity in Asia; Integration of digital navigation systems
Customization Option	Available upon request